Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy

Abstract

Parkinson disease is characterized by the accumulation of aggregated ␣-synuclein as the major component of the Lewy bodies. ␣-Synuclein accumulation in turn leads to compensatory effects that may include the up-regulation of autophagy. Another common feature of Parkinson disease (PD) is mitochondrial dysfunction. Here, we provide evidence that the overactivation of autophagy may be a link that connects the intracellular accumulation of ␣-synuclein with mitochondrial dysfunction. We found that the activation of macroautophagy in primary cortical neurons that overexpress mutant A53T ␣-synuclein leads to massive mitochondrial destruction and loss, which is associated with a bioenergetic deficit and neuronal degeneration. No mitochondrial removal or net loss was observed when we suppressed the targeting of mitochondria to autophagosomes by silencing Parkin, overexpressing wild-type Mitofusin 2 and dominant negative Dynamin-related protein 1 or blocking autophagy by silencing autophagy-related genes. The inhibition of targeting mitochondria to autophagosomes or autophagy was also partially protective against mutant A53T ␣-synuclein-induced neuronal cell death. These data suggest that overactivated mitochondrial removal could be one of the contributing factors that leads to the mitochondrial loss observed in PD models. Mitochondrial dysfunction is one of the hallmarks of Parkinson disease (PD).2 The link between mitochondrial dysfunction and PD was made after the discovery of mitochondrial complex I deficiency in the substantia nigra (1). This connection has been supported by the finding that the products of several PDrelated genes show mitochondrial localization under certain conditions, including SNCA, Parkin, PINK1, DJ-1, LRRK2, and HTR2A (2), and that the mitochondrial toxins MPTP, rotenone, and acetogenins can cause PD (3). A variety of mechanisms have been proposed to explain mitochondrial dysfunction. Oxidative stress, mitochondrial DNA deletions, pathological mutations in genes encoding mitochondrial proteins, altered mitochondrial morphology, and the interaction of pathogenic proteins with mitochondria can all lead to mitochondrial dysfunction and neuronal demise (4).In this study, we propose an intriguing possibility whereby mitochondrial dysfunction may arise from the loss of mitochondria because of the overactivation of autophagy. Signs of autophagy have been detected in the brains of PD patients, whereas autophagosomes are rarely detected in normal brain (5-6). Moreover, several studies have also demonstrated that the overexpression of mutant A53T ␣-synuclein in PC12 cells, cultured neurons, and nigrostriatal systems activates autophagy (7-10). Here, we provide evidence that shows that the up-regulation of macroautophagy by mutant A53T ␣-synuclein can augment mitochondrial removal, which results in a net mitochondrial loss, energetic failure, and neuronal cell death. EXPERIMENTAL PROCEDURESNeuronal Cultures-Primary cultures of rat cortical cells were prepared from neonatal Wistar rats. Briefly, cortices w...

Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction

“…Because Ru360 abolished this effect, we can conclude that the downstream effects of mitochondria-associated ␣Syn were dependent on the uptake of Ca 2ϩ into the mitochondrial matrix. Previous reports suggest that overexpressing ␣Syn in cells or animals leads to alterations in mitochondrial morphology or function in the absence of overt Ca 2ϩ stress (27,31,36,37,58,59,70,71). These results could be explained by one or more of the following possibilities.…”

Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation

“…56,57 Similarly, overexpression of mutant SNCA increases cellular autophagosomes, 58 which actively influences and impacts synaptic functions. Previous studies also demonstrate that both autophagy inducers and inhibitors serve as neuroprotectors against PD.…”

Regulation and Quantification of Cellular Mitochondrial Morphology and Content

“…Another protein involved in Parkinson's disease, α-synuclein, also appears to play a role in mitochondrial quality control. However, the nature of this involvement is currently not fully understood [121][122][123]. Obviously, mitochondrial biogenesis and degradation by mitophagy act antagonistically, but at the same time complementary; and together they determine net mitochondrial content and mitochondrial quality.…”